Viral M45 and necroptosis-associated proteins form heteromeric amyloid assemblies.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
02 2019
Historique:
received: 31 05 2018
revised: 05 11 2018
accepted: 07 11 2018
pubmed: 1 12 2018
medline: 21 4 2020
entrez: 1 12 2018
Statut: ppublish

Résumé

The murine cytomegalovirus protein M45 protects infected mouse cells from necroptotic death and, when heterologously expressed, can protect human cells from necroptosis induced by tumour necrosis factor receptor (TNFR) activation. Here, we show that the N-terminal 90 residues of the M45 protein, which contain a RIP homotypic interaction motif (RHIM), are sufficient to confer protection against TNFR-induced necroptosis. This N-terminal region of M45 drives rapid self-assembly into homo-oligomeric amyloid fibrils and interacts with the RHIMs of the human kinases RIPK1 and RIPK3, and the Z-DNA binding protein 1 (ZBP1), to form heteromeric amyloid fibrils

Identifiants

pubmed: 30498077
pii: embr.201846518
doi: 10.15252/embr.201846518
pmc: PMC6362354
pii:
doi:

Substances chimiques

Amyloid 0
Carrier Proteins 0
Viral Proteins 0
Ribonucleotide Reductases EC 1.17.4.-
m45 protein, Mouse cytomegalovirus 1 EC 1.17.4.-
RIPK1 protein, human EC 2.7.11.1
RIPK3 protein, human EC 2.7.11.1
Receptor-Interacting Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 The Authors.

Références

Nat Neurosci. 2017 Sep;20(9):1236-1246
pubmed: 28758999
Science. 2018 Aug 24;361(6404):810-813
pubmed: 30026316
Cell Host Microbe. 2010 Apr 22;7(4):302-13
pubmed: 20413098
Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2786-E2795
pubmed: 28292903
Sci Signal. 2018 Aug 21;11(544):
pubmed: 30131368
Protein Sci. 2004 May;13(5):1331-9
pubmed: 15096636
Methods Enzymol. 1999;309:285-305
pubmed: 10507031
Adv Protein Chem. 1997;50:123-59
pubmed: 9338080
Int J Mol Sci. 2016 Apr 30;17(5):
pubmed: 27144560
Nat Rev Mol Cell Biol. 2010 Oct;11(10):700-14
pubmed: 20823910
EMBO J. 2017 Sep 1;36(17):2529-2543
pubmed: 28716805
Curr Opin Virol. 2013 Jun;3(3):296-306
pubmed: 23773332
Trends Biochem Sci. 2014 Dec;39(12):587-93
pubmed: 25455759
Semin Cell Dev Biol. 2018 May 22;:
pubmed: 29738881
Cell. 2016 May 19;165(5):1055-1066
pubmed: 27203110
Cell Host Microbe. 2015 Feb 11;17(2):243-51
pubmed: 25674983
Immunity. 2013 Sep 19;39(3):443-53
pubmed: 24012422
EMBO Rep. 2014 Feb;15(2):155-64
pubmed: 24469330
Cell Death Differ. 2014 Oct;21(10):1511-21
pubmed: 24902904
J Biol Chem. 2013 Oct 25;288(43):31268-79
pubmed: 24019532
J Immunol. 2008 Nov 1;181(9):6427-34
pubmed: 18941233
J Biol Chem. 2002 Mar 15;277(11):9505-11
pubmed: 11734559
J Biol Chem. 2008 Jun 20;283(25):16966-70
pubmed: 18442983
J Virol. 2004 Apr;78(8):4278-88
pubmed: 15047841
J Cell Biol. 2015 Aug 17;210(4):529-39
pubmed: 26283796
Nature. 2016 Apr 14;532(7598):245-9
pubmed: 27049944
Immunity. 2017 Oct 17;47(4):635-647.e6
pubmed: 29045898
Science. 2001 Jan 12;291(5502):303-5
pubmed: 11209080
Biophys Rev. 2018 Apr;10(2):527-534
pubmed: 29214606
Viruses. 2012 Oct 02;4(10):1928-49
pubmed: 23202447
Nature. 2016 Dec 1;540(7631):129-133
pubmed: 27819682
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):E804-11
pubmed: 22308366
EMBO Rep. 2009 Aug;10(8):916-22
pubmed: 19590578
Nat Microbiol. 2017 Jan 13;2:16258
pubmed: 28085133
Cell Death Differ. 2014 Nov;21(11):1709-20
pubmed: 24902902
N Engl J Med. 2014 Jan 30;370(5):455-65
pubmed: 24476434
Cell. 2012 May 11;149(4):753-67
pubmed: 22579281
Nature. 2016 Dec 1;540(7631):124-128
pubmed: 27819681
Cell. 2012 Jul 20;150(2):339-50
pubmed: 22817896
FEBS J. 2016 Jul;283(14):2616-25
pubmed: 26395133
Methods Enzymol. 1999;309:274-84
pubmed: 10507030
Sci Rep. 2016 Nov 28;6:37630
pubmed: 27892477
Cell Host Microbe. 2012 Mar 15;11(3):290-7
pubmed: 22423968
Essays Biochem. 2014;56:207-19
pubmed: 25131597
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15438-43
pubmed: 25316792
Med Microbiol Immunol. 2015 Jun;204(3):439-48
pubmed: 25828583
Cell Mol Life Sci. 2016 Jun;73(11-12):2251-67
pubmed: 27048812
Trends Immunol. 2018 Feb;39(2):123-134
pubmed: 29236673
Cell Death Dis. 2018 Jul 26;9(8):816
pubmed: 30050136
J Immunol. 2014 Mar 1;192(5):2019-26
pubmed: 24563506
Cell Host Microbe. 2016 Nov 9;20(5):674-681
pubmed: 27746097
Cell. 2018 May 17;173(5):1244-1253.e10
pubmed: 29681455
Cell Host Microbe. 2015 Feb 11;17(2):229-42
pubmed: 25674982
Semin Cell Dev Biol. 2014 Nov;35:14-23
pubmed: 25087983
Cell Death Differ. 2014 Oct;21(10):1600-12
pubmed: 24902899
Trends Cell Biol. 2015 Jun;25(6):347-53
pubmed: 25662614

Auteurs

Chi Ll Pham (CL)

Discipline of Pharmacology, School of Medical Sciences, Faculty of Medicine and Health and Sydney Nano, University of Sydney, Sydney, NSW, Australia.

Nirukshan Shanmugam (N)

Discipline of Pharmacology, School of Medical Sciences, Faculty of Medicine and Health and Sydney Nano, University of Sydney, Sydney, NSW, Australia.

Merryn Strange (M)

Discipline of Pharmacology, School of Medical Sciences, Faculty of Medicine and Health and Sydney Nano, University of Sydney, Sydney, NSW, Australia.

Ailis O'Carroll (A)

EMBL Australia Node in Single Molecule Sciences, School of Medical Science, University of New South Wales, Sydney, NSW, Australia.

James Wp Brown (JW)

EMBL Australia Node in Single Molecule Sciences, School of Medical Science, University of New South Wales, Sydney, NSW, Australia.

Emma Sierecki (E)

EMBL Australia Node in Single Molecule Sciences, School of Medical Science, University of New South Wales, Sydney, NSW, Australia.

Yann Gambin (Y)

EMBL Australia Node in Single Molecule Sciences, School of Medical Science, University of New South Wales, Sydney, NSW, Australia.

Megan Steain (M)

Infectious Diseases and Immunology, Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Margaret Sunde (M)

Discipline of Pharmacology, School of Medical Sciences, Faculty of Medicine and Health and Sydney Nano, University of Sydney, Sydney, NSW, Australia margaret.sunde@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH